Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins

Molecules

Volumn 19, Issue 6, 2014, Pages 7881-7900

  Lipeeva, Alla V ^a   Shults, Elvira E ^a   Shakirov, Makhmut M ^a   Pokrovsky, Mikhail A ^b   Pokrovsky, Andrey G ^b  

^a N N VOROZHTSOV NOVOSIBIRSK INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Combretastatins; Cytotoxicity; Furocoumarins; Oreoselone; Psoralen; Semi hydrogenation; Sonogashira coupling

Indexed keywords

ANTINEOPLASTIC AGENT; BIBENZYL DERIVATIVE; COMBRETASTATIN; COMBRETASTATIN A4 PHOSPHATE; COUMARIN DERIVATIVE; FUROCOUMARIN DERIVATIVE; OREOSELONE; PSORALEN; STILBENE DERIVATIVE; TUBULIN MODULATOR;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; NEOPLASMS; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIBENZYLS; CELL LINE, TUMOR; COUMARINS; DRUG SCREENING ASSAYS, ANTITUMOR; FICUSIN; FUROCOUMARINS; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN MODULATORS;

EID: 84903308306     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19067881     Document Type: Article

References (37)

1. Pettit, G.R.; Cragg, G.M.; Singh, S.B. Antineoplastic agents, 122. Constituents of Combretum caffrum. J. Nat. Prod. 1987, 50, 386-391.
2. Lin, C.M.; Ho, H.H.; Pettit, G.R.; Hamel, E. Antimitotic natural products combretastatin A-4 and combretastatin A-2: Studies on the mechanism of the ir inhibition of the binding of colchicine to tubulin. Biochemistry 1989, 28, 6984-6991.
3. Bilenker, J.H.; Flaherty, K.T.; Rosen, M.; Davis, L.; Gallagher, M.; Stevenson, J.P.; Sun, W.; Vaughn, D.; Giantonio, B.; Zimmer, R.; et al. Phase I trial of combretastatin A-4 phosphate with carboplatin. Clin. Cancer Res. 2005, 11, 1527-1533.
4. Li, J.; Oyen, R.; Verbruggen, A.; Ni, Y. Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): From Preclinical Experiments towards Possible Clinical Anticancer Applications. J. Cancer 2013, 4, 133-145.
5. Marrelli, M.; Conforti, F.; Statti, G.A.; Cachet, X.; Michel, S.; Tillequin F.; Menichini, F. Biological potential and structure-activity relationships of most recently developed vascular disrupting agents: A n overview of new derivatives of natural combretastatin A-4. Curr. Med. Chem. 2011, 18, 3035-3081.
6. Hatanaka, T.; Fujita, K.; Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Nihei, Y.; Suga, Y.; A kiyama, Y.; Tsuji, T. Novel B-ring modified combretastatin analogues: Syntheses and antineoplastic activity. Bioorg. Med. Chem. Lett. 1998, 8, 3371-3374.
7. Pé rez-Melero, C.; Maya, A.B.; del Rey, B.; Pelá ez, R.; Caballero E.; Medarde, M. A new family of quinoline and quinoxaline analogues of combretastatins. Bioorg. Med. Chem. Lett. 2004, 14, 3771-3774.
8. Pettit, G.R.; Thornhill, A.J.; Mo ser, B.R.; Hogan, F. Antineoplastic Agents. 552. Oxidation of Combretastatin A-1: Trapping the o-quinone intermediate considered the metabolic product of the corresponding phosphate prodrug. J. Nat. Prod. 2008, 71, 1561-1563.
9. Wattanapiromsakul, C.; Chanthathamrongsiri, N.; Bussarawit, S.; Yuenyongsawad, S.; Plubrukarn, A.; Suwanborirux, K. 8-Isocyanoamphilecta-11(20), 15-diene, a new antimalarial isonitrile diterpene from t he sponge Ciocalapata sp. Can. J. Chem. 2009, 87, 612-618.
10. Simoni, D.; Romagnoli, R.; Baruchello, R.; Rondanin, R.; Grisolia, G.; Eleopra, M.; Rizzi, M.; Tolomeo, M.; Giannini, G.; Alloatti, D.; et al. Novel A-Ring and B-Ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. J. Med. Chem. 2008, 51, 6211-6215.
11. Nguyen, T.T.B.; Lomberget, T.; Tran, N.C.; Colomb, E.; Nachtergaele, L.; Thoret, S.; Dubois, J.; Guillaume, J.; Abdayem, R.; Haftek, M.; et al. Synthesis andbiological evaluation of novel het erocyclic derivatives of combretastatin A-4. Bioorg. Med. Chem. Lett. 2012, 22, 7227-7231.
12. Nguyen, T.T.B.; Lomberget, T.; Tran, N.C.; Barret, R. Synthesis of (Z) isomers of benzoheterocyclic deri vatives of combretastatin A-4: A comparative study of several methods. Tetrahedron 2013, 69, 2336-2347.
13. Santana L.; Uriarte, E.; Roleira, F.; Milhazes, N.; Borges, F. Furocoumarins in me dicinal chemistry: Synthesis, natural occurrence and biological activity. Curr. Med. Chem. 2004, 11, 3239-3261.
14. Wu L.,Wang X.,Xu W.,Farzaneh F.,Xu R. The structure and pharmacological functions of coumarins and their derivatives, Curr. Med. Chem., 2009,16, 4236-4260.
15. Conforti, F.; Marrelli, M.; Menichini, F.; Bonesi, M.; Statti, G.; Provenzano, E.; Menichini, F. Nat ural and synthetic furanocoumarins as treatment for Vitiligo and Psoriasis. Curr. Drug Ther. 2009, 4, 38-58.
16. Viola, G.; Vedaldi, D.; Dall ?Acqua, F.; Fortunato, E.; Basso, G.; Bianchi, N.; Zuccato, C.; Borgatti, M.; Lampronti, I.; Gambari, R. Induction of α-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocoumarin derivatives. Biochem. Pharmacol. 2008, 2, 810-825.
17. Salvador, A.; Brognara, E.; Vedaldi, D.; Castagliuolo, I.; Brun, P.; Zuccato, C.; Lampronti I.; Gambari, R. Induction of erythroid differentiation and increased glo bin mRNA production with furocoumarins and their photoproducts. J. Photochem. Photobiol. B Biol. 2013, 121, 57-66.
18. Via, L.D.; Gonzá lez-Gómez, J.C.; Pérez-Montoto, L.G.; Santana, L.; Uriarte, E.; Magno, S.M.; Gia, O. A new psoralen derivative with enlarged antiproliferative properties. Bioorg. Med. Chem. Lett. 2009, 19, 2874-2876.
19. Lipeeva, A.V.; Shul? ts, E.E.; Shakirov, M.M.; Tolstikov, G.A. Plant coumarins. XI. Cross-coupling reactions of 2(tosyl)oreoselone. Russ. J. Org. Chem. 2013, 49, 99-107.
20. Osadchii, S.A.; Shul? ts, E.E.; Shakirov, M.M.; Tolstikov, G.A. Study of Plant Coumarins. 1. Transformations of peucedanin. Russ. Chem. Bull. (Int. Ed.) 2006, 55, 375-379.
21. Lawrence, N.J.; Ghani, F.A.; Hepworth, L.A.; Hadfield, J.A .; McGown, A.T.; Pritchard, R.G. The Synthesis of (E) and (Z)-Combretastatins A-4 and a Phenanthrene from Combretum caffrum. Synthesis 1999, 1656-1660.
22. Lara-Ochoa, F.; Espinosa-Pé rez, G. A new synthesis of combretastatins A-4 and AVE-8062A. Tetrahedron Lett. 2007, 48, 7007-7010.
23. Petrov, O.I.; Gerova, M.S.; Chanev, C.D.; Petrova, K.V. New Efficient Synthesis of Combretastatin A-4 via Colvin Rearrangement. Synthesis 2011, 3711-3715.
24. Lipeeva, A.V.; Shul? ts, E.E.; Bagryanskaya, I.Yu.; Shakirov, M.M.; Tolstikov, G.A. Plant coumarins. VI. Synthesis of 3-vinylfurocoumarin d erivatives based on oreoselone. Russ. J. Org. Chem. 2011, 47, 1083-1090.
25. Lipeeva, A.V.; Shul? ts, E.E.; Shakirov, M.M.; Bagryanskaya, I.Yu.; Tolstikov, G.A. Plant coumarins. XIII. Synthesis of 2,3,9-trisubstituted furocoumarins. Russ. J. Org. Chem. 2013, 49, 403-411.
26. Lipeeva, A.V.; Shul? ts, E.E.; Shakirov, M.M.; Tolstikov, G.A. Synthesis of (Z)-styrylfurocoumarins as the heterocyclic analogues of combretastatins. Dokl. Chem. 2012, 447, 282-285.
27. Wilson, J.K.; Sargent, J.M.; Elgie, A.W.; Hill, J.G.; Taylor, C.G. A feasibility study of the MTT assay for chemosensitivity test ing in ovarian malignancy. Br. J. Cancer 1990, 62, 189-194.
28. Pettit, G.R.; Grealish, M.P.; Jung, M.K.; Hamel, E.; Pettit, R.K.; Chapuis, J.C.; Schmidt, J.M. Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate. J. Med. Chem. 2002, 45, 2534-2542.
29. Gaukroger, K.; Hadfield, J.A.; Lawrence, N.J.; Nolan, S.; McGown, A.T. Stru ctural requirements for the interreaction of combretastatins with tubulin: How important is the trimethoxy uniti Org. Biomol. Chem. 2003, 1, 3033-3037.
30. Á lvarez, C.; Álvarez, R.; Corchete, P.; Pérez-Melero, C.; Pelá ez, R.; Medarde, M. Exploring the effect of 2,3,4-trimethoxy-phenyl moiety as a component of indolephenstatins. Eur. J. Med. Chem. 2010, 45, 588-597.
31. Ferguson, G.; McCrindle, R.; McAlees A.J.; Parvez, M. trans-Dichlorobis(triphenylphosphine)-palladium(II). Acta Cryst. 1982, 38, 2679-2681.
32. Odlo, K.; Hentzen, J.; Fournier dit Chabert, J.; Ducki, S.; Gani, O.A.; Sylte, I.; Skrede, M.; Flören es, V.A.; Hansen, T.V. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorg. Med. Chem. 2008, 16, 4829-4838.
33. Ito, Y.; Aoyama, T.; Shioiri, T. A new preparation of benzofurans utilizing trimethylsilyl-diazomethane. Synlett 1997, 1163-1164.
34. Gangjee, A.; Namjoshi, O.A.; Keller, S.N.; Smith, C.D. 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzylpyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance. Bioorg . Med. Chem. 2011, 19, 4355-4365.
35. Ghasemnejad-Bosra, H.; Ramzanian-Lehmali, F.; Jafari, S. Simple and improved regioselective brominations of aromatic compounds using N-benzyl-N,N-dimethylanilinium peroxo disulfate in the presence of potassium bromide under mild reaction conditions. J. Serb. Chem. Soc. 2011, 76, 685-692.
36. Nair R.N.,Lee P.J.,Grotjahn D.B.,Rheingold A.L. Single bifunctional ru thenium catalyst for one-pot cyclization and hydration giving functionalized indoles and benzofurans, Chem. Eur. J.,2010, 16, 7992-7995.
37. Tajik, H.; Mohammadpoor-Baltork, I.; Albadi, J. Bromination of some aromatic compounds with potassium bromide in the presence of benzyltriphenylphosphonium peroxodisulfate. Synth. Commun. 2007, 37, 323-328.